Corrective and Preventive Action (CAPA) in pharma is the structured system used to eliminate the cause of an existing problem (corrective action) and to prevent potential problems from occurring (preventive action). CAPA is a core element of the Pharmaceutical Quality…
In pharma, an incident is any unplanned event that disrupts normal operations or creates a potential or actual risk to product quality, patient safety, regulatory compliance, data integrity, environment, or worker safety. Incidents can occur in manufacturing, packaging, QC laboratories,…
In pharma, a deviation is any departure from an approved instruction, established procedure, validated process, specification, or expected condition during manufacturing, packaging, testing, storage, or distribution. Deviations matter because they can affect product quality, patient safety, data integrity, and regulatory…
Regulatory affairs (RA) in pharma is a critical function that ensures pharmaceutical products meet legal and safety standards before they reach the market. It involves compliance with national and international regulations governing drug development, approval, manufacturing, marketing, and post-market surveillance.…
Supply Chain Management (SCM) in pharma is the end-to-end control of materials, information, quality, and product flow from API/excipient suppliers to the patient—while maintaining GMP/GDP compliance, preventing counterfeits, and assuring continuous availability. The next layer is materials management and inventory…
Why Pharma Policies Are Important Key Pharma Policies (Typical Set) You can adapt or expand this list based on your company size and complexity. Structure of a Good Pharma Policy A clear policy document usually includes:
Change Control in pharma is the formal, documented system used to propose, evaluate, approve, implement, and review any change that could impact product quality, patient safety, compliance, or data integrity. It is a core element of the Pharmaceutical Quality System…
Calibration in pharma is the documented process of verifying and adjusting instruments so they measure accurately and consistently within defined limits. It is a fundamental GMP requirement because critical decisions—batch release, process control, environmental monitoring, and safety—depend on reliable measurements.…
Batch release in pharma is the formal, documented decision that confirms a manufactured batch is fit for sale and patient use. It verifies that teams produced, tested, packed, stored, and reviewed the batch in compliance with approved procedures, GMP, and…
A pharma warehouse is a GMP/GDP-controlled storage and distribution area that protects raw materials, packaging materials, intermediates, and finished products so they remain identity-preserved, traceable, and within specification until use or dispatch. Warehousing is critical because poor storage can cause…